At GeN we utilize our proprietary technology, Repurposing Platforms to build a clinically rich pipeline and provide therapies to patients. We have been able to complete 100+ projects in this space with varied success in experimental validation and moving the assets forward into the clinics.

GeN provides the necessary infrastructure, workforce, animal models and scientific targets to facilitate the pursuit of a high-level drug validation system in a synergistic environment with a well-established international support network.

GeN Ltd
Office 7 35-37 Ludgate Hill
London, England


diseño alauna